Preliminary results of the use of scalp microneedling in different types of alopecia.
androgenetic alopecia
hair density
hair loss
microneedling
telogen effluvium
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
05
02
2019
accepted:
12
06
2019
pubmed:
30
6
2019
medline:
15
12
2020
entrez:
30
6
2019
Statut:
ppublish
Résumé
Androgenetic alopecia (AGA) is the result of progressive patterned hair density reduction and sometimes can be associated with telogen effluvium (TE). The efficacy of conventional therapy is variable, and therefore, there is a need for adjuvant and newer modalities of treatment in order to give faster and better outcomes. Microneedling has been reported to be a promising, effective, and safe new technique in the treatment of AGA. The aim of this study was to prove that microneedling procedure should be offered to patients with AGA and TE along with the existing therapeutic modalities, in order to obtain faster hair regrowth and, therefore, a better patient compliance. We collected data of 36 females, 29 with AGA, and 7 with TE, and 14 males with AGA between January 2017 and December 2018 and then treated with 3 session of microneedling over a total period of 6 months. No serious adverse side effects were reported. All the patients reported a partial or complete reduction in hair loss, associated to the perception of improvement of hair density and thickening of the hair shaft diameter, results confirmed by clinical iconography and trichoscopy. Scalp areas typical affected by AGA, that is, the vertex in males and the frontal area in females, are the ones that showed the greater percentage of improvement. Moreover, microneedling can have a role also in TE, especially when cosmetic procedures do not give enough results, because it induces a rapid arresting of the hair loss.
Sections du résumé
BACKGROUND
BACKGROUND
Androgenetic alopecia (AGA) is the result of progressive patterned hair density reduction and sometimes can be associated with telogen effluvium (TE). The efficacy of conventional therapy is variable, and therefore, there is a need for adjuvant and newer modalities of treatment in order to give faster and better outcomes. Microneedling has been reported to be a promising, effective, and safe new technique in the treatment of AGA.
OBJECTIVE
OBJECTIVE
The aim of this study was to prove that microneedling procedure should be offered to patients with AGA and TE along with the existing therapeutic modalities, in order to obtain faster hair regrowth and, therefore, a better patient compliance.
PATIENTS AND METHODS
METHODS
We collected data of 36 females, 29 with AGA, and 7 with TE, and 14 males with AGA between January 2017 and December 2018 and then treated with 3 session of microneedling over a total period of 6 months.
RESULTS
RESULTS
No serious adverse side effects were reported. All the patients reported a partial or complete reduction in hair loss, associated to the perception of improvement of hair density and thickening of the hair shaft diameter, results confirmed by clinical iconography and trichoscopy.
CONCLUSIONS
CONCLUSIONS
Scalp areas typical affected by AGA, that is, the vertex in males and the frontal area in females, are the ones that showed the greater percentage of improvement. Moreover, microneedling can have a role also in TE, especially when cosmetic procedures do not give enough results, because it induces a rapid arresting of the hair loss.
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
646-650Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Sinclair RD. Disorders of hair. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. 8th ed. Vol. 4. UK: Blackwell Publishing Ltd; 2010:66.16-66.31.
Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149(1):15-24.
Atanaskova Mesinkovska N, Bergfeld WF. Hair: what is new in diagnosis and management. Female pattern hair loss update: diagnosis and treatment. Dermatol Clin. 2013;31:119-127.
Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
Arora S, Gupta PB. Automated microneedling device-a new tool in dermatologist’s kit-a review. J Pak Med Assoc. 2012;22:354e7.
Singh A, Yadav S. Yadav microneedling: advances and widening horizons Indian. Dermatol Online J. 2016;7(4):244-254.
Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of microneedling in dermatology. Clin Cosmet Investig Dermatol. 2017;10:289-298.
Vedamurthy M. Mesotherapy. Indian J Dermatol Venereol Leprol. 2007;73:60-62.
Escobar-Chávez JJ, Bonilla-Martínez D, Angélica M, et al. Microneedles: A valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol. 2011;51:964-977.
Hou A, Cohen B, Haimovic A, Elbuluk N. Microneedling: A Comprehensive Review. Dermatol Surg 2017; 43: 321-339.
Jeong K, Lee YJ, Kim JE, Park YM, Kim BJ, Kang H. Repeated microneedle stimulation induce the enhanced expression of hair-growth-related genes. Int J Trichology. 2012;4:117.
Kim BJ, Lim YY, Kim HM, et al. Hair follicle regeneration in mice after wounding by microneedle roller. Int J Trichology. 2012;4:117.
Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013;5(1):6-11.
Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss? JEADV. 2018;32:564-569.
Liebl H, Kloth LC. Skin cell proliferation stimulated by microneedles. J Am Coll Clin Wound Spec. 2012;4:2-6.
Jha AK, Udayan UK, Roy PK, Jha Amar AK, Chaudhary R. Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post- treatment evaluation. J Cosmet Dermatol. 2018;17:313-318.